The pathological increase in brain catabolites after traumatic brain injury strongly correlates with a higher risk of neurodegenerative disease. This review examines the pathogenic role of glymphatic clearance dysfunction in that process. The glymphatic network enables cerebrospinal and interstitial fluid exchange and paracellular flow. These processes are mediated by astrocytic aquaporin-4. Glymphatic function is regulated by arterial pulsatility, sleep-wake cycles, and intramural periarterial drainage, with meningeal lymphatic vessels acting as the final drainage site. Mechanical trauma causes aquaporin-4 depolarization and mislocalization; it also triggers neuroinflammatory activation and blood-brain barrier disruption. These processes ultimately impair glymphatic function and neurotoxic proteins become more localized and overproduced. Previous studies have linked clearance defects to secondary neuron injury. Current evidence in humans has come mostly from pilot studies. Recent advances in neuroimaging provide new assessment tools. Dynamic contrast-enhanced magnetic resonance imaging (MRI) reveals delayed tracer clearance. Diffusion tensor imaging along perivascular spaces shows abnormalities in key parameters. These imaging findings preliminarily associate with fluctuations in cerebrospinal fluid catabolites. Therapeutic research suggests several reparative strategies. Physical exercise improves aquaporin-4 polarization integrity. Cannabidiol administration in experimental models increases meningeal lymphatic drainage and reduces tau pathology. Angiotensin II type 1 receptor antagonists may indirectly improve clearance by stabilizing the blood-brain barrier. Lymphatic pathways have been used as therapeutic targets for cannabidiol. Biological evidence also supports their role in traumatic brain injury progression. Further investigation is needed to validate whether these represent independent contributing processes. Multimodal imaging, novel biomarker assays, and chronobiological modulation strategies are improving visualization. Microfluidic modeling could clarify the glymphatic-biomarker relationship; it may also advance precision medicine approaches for traumatic brain injury.
This retrospective study aims to investigate pituitary function 3 years after transsphenoidal surgery in patients with non-functional pituitary neuroendocrine tumor(NF-PitNET) complicated by apoplexy. A retrospective analysis was performed on patients with NF-PitNET who underwent transsphenoidal surgery from January 2016 to September 2020. The patients were divided into apoplexy group and non-apoplexy group based on magnetic resonance imaging(MRI), surgical, and pathological findings. A comparative analysis of pituitary endocrine function was conducted between the two groups at three years postoperatively. A total of 563 patients were initially screened, and 50 matched pairs were included in the study following propensity score matching.Preoperatively, 35 patients in the apoplexy group exhibited pituitary hormone deficiencies, including 2 cases of panhypopituitarism and 14 cases with deficiencies in two or more hormones.In contrast, the non-apoplexy group had 30 patients with pituitary hormone deficiencies, of which 8 had deficiencies in two or more hormones, with no cases of panhypopituitarism.A significant difference was observed in the incidence of ACTH axis deficiency between the two groups (36% vs. 14%, p = 0.011). This trend persisted at the 3-year follow-up, where the apoplexy group continued to show a significantly higher prevalence of ACTH deficiency (34% vs. 16%, p = 0.038).No significant difference was found in the incidence of preoperative LH/FSH axis insufficiency between the groups (38% vs. 40%, p = 0.838).However, at the 3-year follow-up, the apoplexy group exhibited a significantly higher incidence of LH/FSH axis insufficiency compared to the non-apoplexy group (30% vs. 12%, p = 0.027). Additionally, there was no significant difference in the incidence of deficiencies in two or more hormones between the two groups after 3 years of follow-up (39.1% vs. 27.3%, p = 0.705). Pituitary apoplexy is commonly associated with pituitary insufficiency. Patients with preoperative apoplexy are more susceptible to ACTH axis dysfunction compared to those without apoplexy, and they demonstrate significantly poorer recovery of ACTH axis function following transsphenoidal surgery. Additionally, among patients with apoplexy, the postoperative recovery of LH/FSH axis function is also notably inferior to that observed in non-apoplexy patients.
IgG4-related or IgG4-associated hypophysitis is a rare disease characterized by the infiltration of IgG4-positive plasma cells into pituitary gland tissue. Gangliocytomas in the sellar region are also extremely rare and are associated with pituitary adenomas in the majority of cases. Sellar mucosa-associated lymphoid tissue (MALT) lymphoma is an exceedingly rare condition. In this study, we present a case of IgG4-associated hypophysitis coexisting with MALT lymphoma and gangliocytoma. However, to elucidate the potential pathophysiological relationship, it is imperative to gather additional cases of IgG4-related hypophysitis accompanied by MALT lymphoma and gangliocytoma.
Introduction and importance: Contralateral subdural effusion (CSDE) is a rare complication secondary to decompressive craniectomy (DC), which can lead to encephalocele and neurologic deterioration. The authors report a case that confirm the existence of unidirectional membrane valve, and cranioplasty is an effective treatment for CSDE. Case presentation: The authors reported a case of 43-year-old female was diagnosed with ruptured intracranial aneurysm and treated with interventional embolization. She underwent DC because of postoperative cerebral infarction subsequently. Her conscious state deteriorated accompanied by encephalocele in postoperative 2 week. A craniocerebral computed tomography (CT) confirmed the diagnosis of CSDE with cerebral hernia. A compression bandaging of the skull defect was applicated, whereas, her conscious state progressive deteriorated. She was transferred to the author’s hospital where she underwent burr-hole drainage and clinical symptom has been improved. However, a relapse of CSDE was observed after the removal of drainage tube. Continuous lumbar drainage was employed, and which was ineffective for CSDE in this case. Finally, she underwent cranioplasty, with the help of drainage of subdural effusion, CSDE was completely resolved. Clinical discussion: CSDE is occasionally observed in patients after DC. Intracranial pressure (ICP) gradient and unidirectional membrane valve are the possible mechanisms of CSDE. At present, there is no optimal therapy for CSDE. For symptomatic CSDE patients, one or more treatment measures should be applicated. Conclusion: Cranioplasty is one of the curative and optimal method to treat symptomatic CSDE patients, early cranioplasty combined with burr-hole drainage should be performed for conservative treatment failed and intractable cases.
7 August 2026 in Cellular and Molecular Neurobiology
The membrane protein Nogo-A, initially identified for its inhibitory role in axonal regeneration through the Nogo receptor (NgR), is now recognized as a central hub in a complex noncanonical signaling network. Recent evidence indicates that Nogo-A engages diverse receptors and intracellular pathways beyond NgR to modulate neuroplasticity, synaptic stability, and glial function. This multi-target regulatory capacity characterizes Nogo-A as a critical determinant of neural repair and degeneration, with implications for conditions such as spinal cord injury, multiple sclerosis, and Alzheimer’s disease. Noncanonical Nogo-A signaling intersects with growth factor cascades, inflammatory responses, and cytoskeletal dynamics, offering novel therapeutic targets for neural repair. This review synthesizes current knowledge on alternative Nogo-A signaling mechanisms and highlights their potential to redefine strategies for neuroregeneration and disease intervention. Graphical Abstract Noncanonical Nogo-A Signaling Network. This graphical abstract summarizes the Nogo-A signaling network. It illustrates how Nogo-A engages diverse receptors (e.g., PirB, S1PR2) beyond the classical NgR to activate divergent pathways, modulating neuroplasticity and offering novel therapeutic targets for neural repair